EMA: PRELIMINARY DATA INDICATE COVID-19 VACCINES REMAIN EFFECTIVE AGAINST SEVERE DISEASE AND HOSPITALISATION CAUSED BY THE OMICRON VARIANT: 11/01/2022
Ema: Preliminary Data Indicate Covid-19 Vaccines Remain Effective Against Severe Disease And Hospitalisation Caused By The Omicron Variant: 11/01/2022
![Reuters logo](/images/reuters.jpg)